What Researchers Did
Researchers reviewed medical and dental literature to investigate the pathoetiology of bisphosphonate-associated osteonecrosis of the jaws (ONJ) and the potential role of Actinomyces.
What They Found
They found that the exact cause of ONJ remains unknown, with no established primary link to bisphosphonates. However, clinical evidence suggests Actinomyces may play a critical role in its development, and prolonged oral antimicrobial therapy could lead to complete resolution of this actinomycotic osteonecrosis.
What This Means for Canadian Patients
Canadian patients experiencing bisphosphonate-associated ONJ may benefit from diagnostic efforts to identify Actinomyces infection. If confirmed, a prolonged course of oral antimicrobial therapy could offer a path to complete resolution of their condition.
Canadian Relevance
This study has no direct Canadian connection as indicated by the metadata.
Study Limitations
As a literature review, this study's findings are based on existing evidence, and the exact pathoetiology of ONJ remains unknown, highlighting the need for further definitive research.